Correction: A critical reappraisal of vasopressin and steroids in in-hospital cardiac arrest,Critical Care

当前位置： X-MOL 学术 › Crit. Care › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Correction: A critical reappraisal of vasopressin and steroids in in-hospital cardiac arrest
Critical Care ( IF 8.8 ) Pub Date : 2024-08-15 , DOI: 10.1186/s13054-024-05043-6
Spyros D Mentzelopoulos _{1,

2} , Athanasios Chalkias _{3,

4}

Affiliation

Correction: Mentzelopoulos and Chalkias Critical Care (2024) 28:191 https://doi.org/10.1186/s13054-024-04962-8

Following publication of the original article [1], the authors identified an error within row 7 of Table 2. In Table 2, row 7, the lowest percentages of postresuscitation hypotension (i.e. 17% and 15%) actually correspond to the intervention group(s) and the highest (i.e. 28% and 29%) to control.

Table 2 row 7 currently reads:

Lowest MAP ≤ 50 mmHg and SAP ≤ 80 mmHg, intervention group(s) versus control (%)

28% versus 17%—P = 0.12 and 29% versus 15%; P = 0.03^d

NR but significant difference unlikely^c

Table 2 Key differences between the Greek VSE trials and the Danish VAM IHCA trial

Full size table

]

Table 2 row 7 should read:

Lowest MAP ≤ 50 mmHg and SAP ≤ 80 mmHg, intervention group(s) versus control (%)

17% versus 28%—P = 0.12 and 15% versus 29%; P = 0.03^d

NR but significant difference unlikely^c

Table 2 Key differences between the Greek VSE trials and the Danish VAM IHCA trial

Full size table

]

Table 2 has been updated in this correction and the original article [1] has been corrected.

Mentzelopoulos SD, Chalkias A. A critical reappraisal of vasopressin and steroids in in-hospital cardiac arrest. Crit Care. 2024;28:191. https://doi.org/10.1186/s13054-024-04962-8.
Article PubMed PubMed Central Google Scholar

Download references

Authors and Affiliations

First Department of Intensive Care Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Spyros D. Mentzelopoulos
Department of Intensive Care Medicine, Evaggelismos General Hospital, 45‑47 Ipsilandou St, 10675, Athens, Greece
Spyros D. Mentzelopoulos
Institute for Translational Medicine and Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104‑5158, USA
Athanasios Chalkias
Outcomes Research Consortium, Cleveland, OH, 44195, USA
Athanasios Chalkias

Authors

Spyros D. MentzelopoulosView author publications
You can also search for this author in PubMed Google Scholar
Athanasios ChalkiasView author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Spyros D. Mentzelopoulos.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

Cite this article

Mentzelopoulos, S.D., Chalkias, A. Correction: A critical reappraisal of vasopressin and steroids in in-hospital cardiac arrest. Crit Care 28, 273 (2024). https://doi.org/10.1186/s13054-024-05043-6

Download citation

Published: 15 August 2024
DOI: https://doi.org/10.1186/s13054-024-05043-6

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

中文翻译：

纠正：对院内心脏骤停中加压素和类固醇的严格重新评估

更正：Mentzelopoulos 和 Chalkias 重症监护 (2024) 28:191 https://doi.org/10.1186/s13054-024-04962-8

原文章 [1] 发表后，作者发现表 2 第 7 行存在错误。在表 2 第 7 行中，复苏后低血压的最低百分比（即 17% 和 15%）实际上对应于干预组（ s)和最高(即28%和29%)来控制。

表 2 第 7 行当前内容为：

干预组与对照组的最低 MAP ≤ 50 mmHg 和 SAP ≤ 80 mmHg (%)

28% 与 17% — P = 0.12 以及 29% 与 15%； P = 0.03^天

NR 但不太可能出现显着差异^c

表 2 希腊 VSE 试验和丹麦 VAM IHCA 试验之间的主要区别

全尺寸桌子

]

表 2 第 7 行应为：

干预组与对照组的最低 MAP ≤ 50 mmHg 和 SAP ≤ 80 mmHg (%)

17% 与 28% — P = 0.12 以及 15% 与 29%； P = 0.03^天

NR 但不太可能出现显着差异^c

表 2 希腊 VSE 试验和丹麦 VAM IHCA 试验之间的主要区别

全尺寸桌子

]

本次更正更新了表2，并对原文章[1]进行了更正。

Mentzelopoulos SD，Chalkias A.对院内心脏骤停中加压素和类固醇的批判性重新评估。危重护理。 2024；28：191。 https://doi.org/10.1186/s13054-024-04962-8。

文章 PubMed PubMed Central Google Scholar

下载参考资料

作者和单位

雅典国立卡波季斯特里亚大学医学院重症监护医学第一系，希腊雅典
斯皮罗斯·门泽洛普洛斯
重症监护医学部，Evaggelismos 综合医院，45-47 Ipsilandou St, 10675, Athens, Greek
斯皮罗斯·门泽洛普洛斯
宾夕法尼亚大学佩雷尔曼医学院转化医学和治疗研究所，费城，宾夕法尼亚州，19104-5158，美国
阿萨纳西奥斯·查尔基亚斯
结果研究联盟，克利夫兰，俄亥俄州，44195，美国
阿萨纳西奥斯·查尔基亚斯

作者

Spyros D. Mentzelopoulos查看作者出版物

您也可以在PubMed中搜索该作者谷歌学术
Athanasios Chalkias查看作者出版物

您也可以在PubMed中搜索该作者谷歌学术

通讯作者

通讯作者：Spyros D. Mentzelopoulos。

出版商备注

施普林格·自然对于已出版的地图和机构隶属关系中的管辖权主张保持中立。

开放获取本文根据知识共享署名 4.0 国际许可证获得许可，该许可证允许以任何媒介或格式使用、共享、改编、分发和复制，只要您对原作者和来源给予适当的认可，提供知识共享许可证的链接，并指出是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可中，除非材料的出处中另有说明。如果文章的知识共享许可中未包含材料，并且您的预期用途不受法律法规允许或超出了允许的用途，则您需要直接获得版权所有者的许可。要查看此许可证的副本，请访问 http://creativecommons.org/licenses/by/4.0/。知识共享公共领域奉献豁免 (http://creativecommons.org/publicdomain/zero/1.0/) 适用于本文中提供的数据，除非数据的信用额度中另有说明。

转载和许可